PFE vs UNH: Which Is the Better Buy?
Side-by-side comparison of Pfizer Inc. and UnitedHealth Group Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-17.
Pfizer Inc. · Healthcare
$25.22
+2.8% upside to fair value
Grade B
VS
UnitedHealth Group Incorporated · Healthcare
$423.38
+45.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
UNH has more upside to fair value
(+45.0%).
PFE trades at a lower forward P/E
(19.2x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
PFE |
UNH |
| Current Price |
$25.22 |
$423.38 |
| Fair Value Estimate |
$25.92 |
$613.90 |
| Upside to Fair Value |
+2.8%
|
+45.0%
|
| Market Cap |
$143.7B |
$384.5B |
| Forward P/E |
19.2x
|
27.2x
|
| EV / EBITDA |
12.3x
|
13.8x
|
| Price / Sales |
2.3x
|
0.8x
|
| Price / FCF |
15.2x
|
19.6x
|
| Revenue Growth YoY |
+5.4%
|
+0.4%
|
| Gross Margin |
69.3%
|
18.8%
|
| Operating Margin |
23.4%
|
4.2%
|
| Return on Equity |
8.4%
|
12.4%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
6.6%
|
5.12%
|
| Analyst Consensus |
Hold
|
Strong Buy
|
Investment Thesis
Pfizer Inc. is a leading global biopharmaceutical company with a diversified portfolio dominated by its Biopharma prescription segment, which accounts for over 90% of revenue. The company benefits from a substantial scale, a broad product portfolio including top-selling drugs like Eliquis, Prevnar, and Paxlovid, and a strong manufacturing footprint. However, Pfizer faces challenges from declining…
UnitedHealth Group Incorporated operates in the healthcare sector, specifically within medical and healthcare plans, providing a durable business model supported by a strong competitive moat and consistent earnings growth. The company currently trades at a price of $423.38 with a market cap of $359.873 billion, reflecting a valuation that is cheap relative to its five-year history, supported by a…
Accumulation Zones
| Metric |
PFE |
UNH |
| Zone Low |
$19.44 |
$460.42 |
| Zone High |
$22.03 |
$521.81 |
| In Buy Zone? |
No
|
Yes
|